Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Drug developer Tesaro explores sale

      Drug developer Tesaro explores sale

      Medical Dialogues Bureau19 Nov 2018 9:00 AM IST
      New Delhi: Cancer Drug Developer Tesaro Inc is exploring a sale and is working with financial advisers after receiving takeover interest, Bloomberg...
      Ranbaxy beats class certification bid in case over contamination threat

      Ranbaxy beats class certification bid in case over contamination threat

      Medical Dialogues Bureau18 Nov 2018 12:30 PM IST
      New Delhi: A federal judge has refused to certify a class of consumers who sued India’s Ranbaxy Laboratories Ltd to obtain a refund for generic...
      Parnax Lab settles case with SEBI, pays over Rs 10 lakh

      Parnax Lab settles case with SEBI, pays over Rs 10 lakh

      Medical Dialogues Bureau18 Nov 2018 11:45 AM IST
      New Delhi: Pharmaceutical company Parnax Lab has settled proceedings with markets regulator SEBI in connection with alleged violation of listing norms...
      Novartis blood disorder drug Promacta  gets FDA approval

      Novartis blood disorder drug Promacta gets FDA approval

      Medical Dialogues Bureau18 Nov 2018 11:00 AM IST
      Promacta has been approved in more than 90 countries as a treatment for low platelet count in patients with chronic immune thrombocytopenic...
      Shilpa Medicare gets tentative USFDA nod for Multiple Sclerosis drug

      Shilpa Medicare gets tentative USFDA nod for Multiple Sclerosis drug

      Medical Dialogues Bureau18 Nov 2018 10:15 AM IST
      New Delhi: Shilpa Medicare has recently received tentative approval from the US health regulator for Dimethyl Fumarate delayed-release release...
      Eli Lilly considers sale of off-patent drug assets in China

      Eli Lilly considers sale of off-patent drug assets in China

      Medical Dialogues Bureau18 Nov 2018 9:45 AM IST
      New Delhi: Eli Lilly and Co are considering the sale of an off-patent drugs portfolio in China, Bloomberg reported on Friday, citing sources.The...
      Pfizer Q2 net profit falls 14% to Rs 95.8 crore

      Pfizer Q2 net profit falls 14% to Rs 95.8 crore

      Medical Dialogues Bureau18 Nov 2018 9:00 AM IST
      New Delhi: Drug firm Pfizer has recently reported a 13.81 per cent dip in standalone net profit to Rs 95.8 crore for the quarter ended September...
      Expired medicines sold by re-stamping: HC asks Govt to intervene

      Expired medicines sold by re-stamping: HC asks Govt to intervene

      Medical Dialogues Bureau17 Nov 2018 2:34 PM IST
      The plea said, "expired medicines sold as un-expired not only affect the health of the affected person(s), but the same leads to unnecessary financial...
      Zydus Cadila gets USFDA nod to market generic HIV treatment tablets

      Zydus Cadila gets USFDA nod to market generic HIV treatment tablets

      Medical Dialogues Bureau17 Nov 2018 11:45 AM IST
      Ahmedabad: Zydus Cadila has recently received the final approval from the USFDA to market Abacavir and Lamivudine Tablets USP, 600 mg/300 mg, and...
      Merck Foundation announces winners for Merck Diabetes Award 2018

      Merck Foundation announces winners for Merck Diabetes Award 2018

      Medical Dialogues Bureau17 Nov 2018 11:20 AM IST
      Merck Foundation marked the “World Diabetes Day” themed ‘The Family and Diabetes’ on 14th November 2018. Merck Foundation to provide One Year on-line...
      Glenmark gets USFDA nod for Teriflunomide Tablets

      Glenmark gets USFDA nod for Teriflunomide Tablets

      Medical Dialogues Bureau17 Nov 2018 11:00 AM IST
      Mumbai: Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for...
      Bayer CropScience Q2 net profit down 25.13 percent

      Bayer CropScience Q2 net profit down 25.13 percent

      Medical Dialogues Bureau17 Nov 2018 10:15 AM IST
      New Delhi: Agro-chemical firm Bayer CropScience has recently posted 25.13 per cent drop in its net profit at Rs 142.7 crore in the second quarter of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok